UGT1A1*6 AND UGT1A1*27 ARE ASSOCIATED WITH IRINOTECAN-INDUCED SEVERE NEUTROPENIA IN JAPANESE PATIENTS WITH NSCLC

被引：0
|
作者：
Doi, S. [1 ]
Nakamura, Y. [1 ]
Fukuda, M. [2 ,3 ]
Takatani, H. [2 ]
Fukuda, M. [2 ,3 ]
Kinoshita, A. [4 ]
Soda, H. [5 ]
Oka, M. [6 ]
Tsukamoto, K. [7 ]
Kohno, S. [1 ]
机构：
[1] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan
[2] Japanese Red Cross Nagasaki Atom Bomb Hosp, Nagasaki, Japan
[3] Nagasaki Municipal Hosp, Nagasaki, Japan
[4] NHO Nagasaki Med Ctr, Ohmura, Japan
[5] Sasebo Gen Hosp, Sasebo, Japan
[6] Kawasaki Med Sch, Div Resp Dis, Kurashiki, Okayama 70101, Japan
[7] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmacotherapeut, Nagasaki 852, Japan
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [31] UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis
    Zhang, Xue
    Yin, Jia-Fu
    Zhang, Jiao
    Kong, Shu-Jia
    Zhang, Hong-Yin
    Chen, Xue-Mei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 135 - 149
  • [32] UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis
    Xue Zhang
    Jia-Fu Yin
    Jiao Zhang
    Shu-Jia Kong
    Hong-Yin Zhang
    Xue-Mei Chen
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 135 - 149
  • [33] Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia
    Teh, L. K.
    Hashim, H.
    Zakaria, Z. A.
    Salleh, M. Z.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 136 (02) : 249 - 259
  • [34] Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia
    Nakamura, Yoichi
    Soda, Hiroshi
    Oka, Mikio
    Kinoshita, Akitoshi
    Fukuda, Minoru
    Fukuda, Masaaki
    Takatani, Hiroshi
    Nagashima, Seiji
    Soejima, Yoshifumi
    Kasai, Takashi
    Nakatomi, Katsumi
    Masuda, Noriyuki
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 121 - 127
  • [35] Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan
    Takano, Masashi
    Kato, Masafumi
    Yoshikawa, Tomoyuki
    Goto, Tomoko
    Furuya, Kenichi
    Kikuchi, Yoshihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (02) : 224 - 225
  • [36] Irinotecan pharmacogenetics in Japanese cancer patients:: Roles of UGT1A1*6 and*28
    Sai, Kirnie
    Sawada, Jun-Ichi
    Minami, Hironobu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 (04): : 575 - 584
  • [37] Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan
    Masashi Takano
    Masafumi Kato
    Tomoyuki Yoshikawa
    Tomoko Goto
    Kenichi Furuya
    Yoshihiro Kikuchi
    International Journal of Clinical Oncology, 2010, 15 : 224 - 225
  • [38] Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer
    Fukuda, Minoru
    Okumura, Manabu
    Iwakiri, Tomomi
    Arimori, Kazuhiko
    Honda, Takuya
    Kobayashi, Kazuma
    Senju, Hiroaki
    Takemoto, Shinnosuke
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Matsuo, Nobuko
    Mukae, Hiroshi
    Ashizawa, Kazuto
    THORACIC CANCER, 2018, 9 (01) : 51 - 58
  • [39] UGT1A1 genotyping and neutropenia risk
    Vasconcelos, Alberto
    LANCET ONCOLOGY, 2007, 8 (10): : 873 - 873
  • [40] The Relationship between the UGT1A1*27 and UGT1A1*7 Genetic Polymorphisms and Irinotecan-Related Toxicities in Patients with Lung Cancer
    Fukuda, M.
    Okumura, M.
    Arimori, K.
    Takahira, A.
    Mori, M.
    Nakamura, D.
    Shimada, M.
    Taniguchi, H.
    Gyotoku, H.
    Senju, H.
    Ikeda, T.
    Yamaguchi, H.
    Nakatomi, K.
    Tsuchiya, T.
    Mukae, H.
    Ashizawa, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1955 - S1955
12345